Table 3.

When to Prefer Triple Therapy FDCs Over Dual Bronchodilation

Immediate choice in

• Patients who present for the first time, and have severe airway obstruction (FEV1 <50%) and are symptomatic

• Patients who have had frequent (≥2) moderate or severe exacerbations (≥1 hospitalisation) in the previous year

• Patients who have peripheral eosinophilia (>300 cells·μL−1)

• Patients with significant lung function decline

• Patients discharged from hospital after a COPD exacerbation.